ZURICH/BEIJING (Reuters) - Drug maker Novartis on Thursday trumpeted the effectiveness of a single dose of its anti-swine flu vaccine, boosting hopes that potentially tight supplies could go further when mass immunisation programmes start this month.
The outbreak of the H1N1 strain of flu, declared a pandemic on June 11, has spread around the world and could eventually affect 2 billion people, according to World Health Organisation estimates
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
